Last update 04 Apr 2026

GS-4321

Overview

Basic Info

Drug Type
Antibody
Synonyms
GS-4321
Target
HDV pre-S1
Action
inhibitors
Mechanism
HDV pre-S1 inhibitors(HDV pre-S1 inhibitors)
Therapeutic Areas
Infectious DiseasesDigestive System DisordersOther Diseases
Active Indication
Hepatitis D, Chronic
Inactive Indication-
Originator Organization
Gilead Sciences, Inc.Gilead Sciences, Inc.
Active Organization
Gilead Sciences, Inc.Gilead Sciences, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with GS-4321
NCT07096193
/ RecruitingPhase 1/2
Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta
100 Clinical Results associated with GS-4321
Login to view more data
100 Translational Medicine associated with GS-4321
Login to view more data
100 Patents (Medical) associated with GS-4321
Login to view more data
100 Deals associated with GS-4321
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis D, ChronicPhase 2
United States
Gilead Sciences, Inc.Gilead Sciences, Inc.
31 Jul 2025
Hepatitis D, ChronicPhase 2
Moldova
Gilead Sciences, Inc.Gilead Sciences, Inc.
31 Jul 2025
Hepatitis D, ChronicPhase 2
Romania
Gilead Sciences, Inc.Gilead Sciences, Inc.
31 Jul 2025
Hepatitis D, ChronicPhase 2
South Korea
Gilead Sciences, Inc.Gilead Sciences, Inc.
31 Jul 2025
Hepatitis D, ChronicPhase 2
Taiwan Province
Gilead Sciences, Inc.Gilead Sciences, Inc.
31 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free